RayzeBio is a dynamic biotechnology company headquartered in San Diego, CA. Launched in late 2020 and acquired by Bristol Myers Squibb (BMS) in 2024 as a wholly owned subsidiary, the company is focused on improving survival of people with cancer by harnessing the power of targeted radioisotopes. RayzeBio operates as a standalone entity within the BMS organization, maintaining its biotech culture with the opportunity to leverage the best-in-class oncology capabilities of BMS. RayzeBio is developing innovative drugs against targets of solid tumors. The lead asset, RYZ101, is in Phase 3 testing for patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs). In addition, Rayzebio has the leading radiopharmaceuticals pipeline with novel assets targeting HCC, RCC and Prostate cancer amongst others. Led by a successful and experienced entrepreneurial team, RayzeBio aims to be the global leader in radiopharmaceuticals.

Position Summary
Reporting directly to the President of RayzeBio, the Vice President, Data, Analytics, AI & Technology is a critical leadership role responsible for driving data-driven decision-making, digital transformation, and scalable technology enablement across the organization. This leader owns the enterprise data and analytics strategy, AI/ML capabilities, and core technology platforms that support RayzeBio end-to-end-from research through drug development, manufacturing, and commercialization.

As a wholly owned subsidiary, this role requires strong partnership with BMS functions (e.g., IT, Business Insights & Analytics, data platforms) while tailoring solutions for RayzeBio's pace, culture, and operating model. The ideal candidate brings an entrepreneurial mindset, a bias for action, and the ability to challenge the organization to think bigger-pushing leaders and teams beyond their comfort zones on what's possible with data, automation, and AI.

Key Responsibilities

• Develop and execute an enterprise digital strategy aligned to RayzeBio's business objectives, driving operational efficiency, smarter decisions, and cross-functional collaboration.
• Lead digital transformation initiatives that modernize data and reporting, streamline workflows, and accelerate execution through automation and AI/ML where it creates tangible business value.
• Identify and prioritize high-impact opportunities to simplify the operating environment - reducing tool sprawl, minimizing friction, and improving speed without sacrificing quality or compliance.
• Own the enterprise analytics and AI/ML roadmap, prioritizing practical use cases across research, development, manufacturing, and commercial readiness.
• Oversee advanced analytics capabilities - including predictive modeling, forecasting, and machine learning - to support data-driven decision-making across functions.
• Establish fit-for-purpose data governance, ensuring data quality, integrity, security, and cross-functional accessibility.
• Bring an external perspective on emerging technologies and translate them into pragmatic, adoption-ready tools and approaches that RayzeBio teams can and will use.
• Partner closely with Research and Drug Development leadership to leverage data, analytics, and AI across the drug development lifecycle - from discovery and translational science through clinical development and CMC.
• Improve how data is captured, integrated, and used across preclinical, clinical, and manufacturing interfaces to increase insight quality, reproducibility, and execution readiness.
• Enable practical analytics and AI use cases that support development execution - including trial planning, study performance visibility, and decision support - while remaining compliant and fit for purpose.
• Lead data and analytics capabilities supporting commercial readiness and launch execution, including forecasting, scenario modeling, and performance analytics aligned to demand, supply, and revenue planning.
• Enable commercial teams with the tools, infrastructure, and insights needed to support go-to-market execution, customer engagement, and post-launch optimization.
• Partner closely with Commercial, Medical Affairs, Manufacturing, and Supply Chain to ensure analytic and technology readiness for launch and scaled commercialization.
• Own RayzeBio's technology ecosystem - infrastructure, applications, collaboration tools, and data platforms - ensuring scalability, security, and compliance.
• Ensure technology decisions are practical and user-centered - prioritizing adoption and real-world utility over technical sophistication for its own sake.
• Partner with BMS IT, analytics, and data organizations to leverage enterprise platforms while ensuring solutions remain tailored to RayzeBio's scale and operating model.
• Attract, develop, and retain top talent across data science, analytics, AI/ML, and technology; build a culture of innovation, ownership, and measurable impact.
• Lead effectively across a distributed, multi-site organization - driving clear priorities, transparent communication, and strong execution rhythms.
• Serve as a member of the RayzeBio leadership team; challenge assumptions, elevate thinking, and drive adoption of data-driven and AI-enabled ways of working across the organization.

Qualifications and Experience

• Bachelor's degree required; advanced degree (MS, PhD, MBA) preferred depending on background and domain depth.
• 15+ years of progressive leadership experience across data/analytics, digital, AI/ML, and technology in biotech, pharma, life sciences, or similarly complex regulated environments.
• Senior leadership experience owning enterprise platforms, analytics strategy, and cross-functional delivery across multiple sites.
• Strong understanding of the biotech/pharma value chain (research, drug development, manufacturing, commercialization); heavier research exposure preferred.
• Track record of delivering measurable business impact through analytics, digital enablement, and/or AI-beyond experimentation.
• Demonstrated ability to operate effectively within a larger enterprise ecosystem while tailoring solutions for a smaller, high-speed subsidiary environment.

#LI-Hybrid

#RayzeBio

Compensation Overview:

$307,190 - $372,242

Compensation Overview:

The starting compensation range(s) for this role are listed above for a full-time employee (FTE) basis. Additional incentive cash and stock opportunities (based on eligibility) may be available. The starting pay rate takes into account characteristics of the job, such as required skills, where the job is performed, the employee's work schedule, job-related knowledge, and experience. Final, individual compensation will be decided based on demonstrated experience.

Eligibility for specific benefits listed on our careers site may vary based on the job and location. For more on benefits, please visit https://careers.bms.com/life-at-bms/.

Benefit offerings are subject to the terms and conditions of the applicable plans in effect at the time and may require enrollment. Our benefits include:

• Health Coverage: Medical, pharmacy, dental, and vision care.
• Wellbeing Support: Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
• Financial Well-being and Protection: 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.

Work-life benefits include:

Paid Time Off

• US Exempt Employees: flexible time off (unlimited, with manager approval, 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees)
• Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non-Exempt, Hourly Employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays

Based on eligibility*, additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day.

All global employees full and part-time who are actively employed at and paid directly by BMS at the end of the calendar year are eligible to take advantage of the Global Shutdown.

*Eligibility Disclosure: The summer hours program is for United States (U.S.) office-based employees due to the unique nature of their work. Summer hours are generally not available for field sales and manufacturing operations and may also be limited for the capability centers. Employees in remote-by-design or lab-based roles may be eligible for summer hours, depending on the nature of their work, and should discuss eligibility with their manager. Employees covered under a collective bargaining agreement should consult that document to determine if they are eligible. Contractors, leased workers and other service providers are not eligible to participate in the program.